BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• 

  Opinion

  iPSCs come of age, powering breakthroughs in the lab and clinic

  After years of quiet maturation, new approach methodologies and emerging clinical success for cell therapies are fueling parallel momentum for induced pluripotent stem cells.

  October 16, 2026

   · 

  5 min read

   · 

  Nina Bauer
• Press Releases

  Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer

  October 16, 2026

   · 

  6 min read
• Press Releases

  FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)

  October 16, 2026

   · 

  10 min read
• Press Releases

  FDA Approves Genentech’s Enspryng, a First-in-Class IL-6R Inhibitor, as the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)

  October 16, 2026

   · 

  11 min read
• Press Releases

  IBA and Framatome join forces to industrialize Astatine-211 production for cancer therapies

  October 16, 2026

   · 

  4 min read
• Press Releases

  Three Orelabrutinib Studies Presented in Oral Sessions at the 88th Annual Meeting of the Japanese Society of Hematology

  October 16, 2026

   · 

  3 min read
• Press Releases

  Senturi Pharma announces exclusive European distribution agreement for PERTZYE®

  October 16, 2026

   · 

  1 min read
• 

  Manufacturing

  FDA issues warning over Eurofins’ selective recording that ‘compromises’ data

  Inconsistent reporting at a Pennsylvania site affected microbiological analyses of components and drug products that analytical testing service provider Eurofins ran for customers.

  October 16, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor
• Press Releases

  Study Finds Treating Depression During Pregnancy May Benefit Babies’ Brain Development

  October 16, 2026

   · 

  4 min read
• Press Releases

  Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMA

  October 16, 2026

   · 

  9 min read